Which has stronger earnings & valuation, WAT or BRKR?

Waters has higher earnings, but lower revenue than Bruker. Bruker is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waters $3.17B 13.24 $642.63M $4.01 106.36 Bruker $3.44B 2.84 -$8.60M -$0.70 N/A

Is WAT or BRKR more profitable?

Waters has a net margin of 3.58% compared to Bruker's net margin of -2.35%. Bruker's return on equity of 12.47% beat Waters' return on equity. Company Net Margins Return on Equity Return on Assets Waters 3.58% 11.27% 6.73% Bruker -2.35% 12.47% 4.91%

Does the media favor WAT or BRKR?

In the previous week, Waters had 8 more articles in the media than Bruker. MarketBeat recorded 13 mentions for Waters and 5 mentions for Bruker. Bruker's average media sentiment score of 0.34 beat Waters' score of 0.18 indicating that Bruker is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waters 3 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Bruker 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation and earnings, RGEN or WAT?

Waters has higher revenue and earnings than Repligen. Waters is trading at a lower price-to-earnings ratio than Repligen, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Repligen $738.26M 14.14 $48.89M $0.73 253.43 Waters $3.17B 13.24 $642.63M $4.01 106.36

Is RGEN or WAT more profitable?

Repligen has a net margin of 5.29% compared to Waters' net margin of 3.58%. Waters' return on equity of 11.27% beat Repligen's return on equity. Company Net Margins Return on Equity Return on Assets Repligen 5.29% 5.30% 3.79% Waters 3.58% 11.27% 6.73%

Does the media prefer RGEN or WAT?

In the previous week, Waters had 2 more articles in the media than Repligen. MarketBeat recorded 13 mentions for Waters and 11 mentions for Repligen. Repligen's average media sentiment score of 0.23 beat Waters' score of 0.18 indicating that Repligen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Repligen 1 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Waters 3 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation & earnings, WAT or TECH?

Waters has higher revenue and earnings than Bio-Techne. Bio-Techne is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waters $3.17B 13.24 $642.63M $4.01 106.36 Bio-Techne $1.22B 9.35 $181.86M $1.15 62.96

Is WAT or TECH more profitable?

Bio-Techne has a net margin of 14.97% compared to Waters' net margin of 3.58%. Bio-Techne's return on equity of 13.23% beat Waters' return on equity. Company Net Margins Return on Equity Return on Assets Waters 3.58% 11.27% 6.73% Bio-Techne 14.97% 13.23% 10.61%

Does the media prefer WAT or TECH?

In the previous week, Waters had 9 more articles in the media than Bio-Techne. MarketBeat recorded 13 mentions for Waters and 4 mentions for Bio-Techne. Waters' average media sentiment score of 0.18 beat Bio-Techne's score of 0.07 indicating that Waters is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waters 3 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Bio-Techne 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, A or WAT?

Agilent Technologies has higher revenue and earnings than Waters. Agilent Technologies is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Agilent Technologies $6.95B 6.83 $1.30B $5.08 33.11 Waters $3.17B 13.24 $642.63M $4.01 106.36

Does the media refer more to A or WAT?

In the previous week, Waters had 1 more articles in the media than Agilent Technologies. MarketBeat recorded 13 mentions for Waters and 12 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 0.29 beat Waters' score of 0.18 indicating that Agilent Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 2 Very Positive mention(s) 0 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Waters 3 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings & valuation, DHR or WAT?

Danaher has higher revenue and earnings than Waters. Danaher is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Danaher $24.57B 6.15 $3.61B $5.63 38.20 Waters $3.17B 13.24 $642.63M $4.01 106.36

Is DHR or WAT more profitable?

Danaher has a net margin of 15.95% compared to Waters' net margin of 3.58%. Waters' return on equity of 11.27% beat Danaher's return on equity. Company Net Margins Return on Equity Return on Assets Danaher 15.95% 11.04% 6.81% Waters 3.58% 11.27% 6.73%

Does the media favor DHR or WAT?

In the previous week, Danaher had 1 more articles in the media than Waters. MarketBeat recorded 14 mentions for Danaher and 13 mentions for Waters. Danaher's average media sentiment score of 0.96 beat Waters' score of 0.18 indicating that Danaher is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Danaher 7 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Waters 3 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Waters (WAT) Competitors

$425.59 +0.06 (+0.01%)

Closing price 03:59 PM Eastern

Extended Trading

$425.26 -0.33 (-0.08%)

As of 04:26 PM Eastern

Compare

WAT vs. BRKR, RGEN, TECH, A, and DHR

Should you buy Waters stock or one of its competitors? Waters's main competitors and comparable companies include Bruker (BRKR), Repligen (RGEN), Bio-Techne (TECH), Agilent Technologies (A), and Danaher (DHR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Waters compare to Bruker?

Waters (NYSE:WAT) and Bruker (NASDAQ:BRKR) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability.

In the previous week, Waters had 8 more articles in the media than Bruker. MarketBeat recorded 13 mentions for Waters and 5 mentions for Bruker. Bruker's average media sentiment score of 0.34 beat Waters' score of 0.18 indicating that Bruker is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waters	3 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Bruker	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

94.0% of Waters shares are held by institutional investors. Comparatively, 79.5% of Bruker shares are held by institutional investors. 0.3% of Waters shares are held by company insiders. Comparatively, 27.2% of Bruker shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Waters has higher earnings, but lower revenue than Bruker. Bruker is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waters	$3.17B	13.24	$642.63M	$4.01	106.36
Bruker	$3.44B	2.84	-$8.60M	-$0.70	N/A

Waters has a net margin of 3.58% compared to Bruker's net margin of -2.35%. Bruker's return on equity of 12.47% beat Waters' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waters	3.58%	11.27%	6.73%
Bruker	-2.35%	12.47%	4.91%

Waters has a beta of 1.15, indicating that its share price is 15% more volatile than the broader market. Comparatively, Bruker has a beta of 1.22, indicating that its share price is 22% more volatile than the broader market.

Waters currently has a consensus target price of $437.10, indicating a potential upside of 2.48%. Bruker has a consensus target price of $57.86, indicating a potential downside of 9.56%. Given Waters' stronger consensus rating and higher probable upside, equities research analysts plainly believe Waters is more favorable than Bruker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waters	0 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	3 Strong Buy rating(s)	2.85
Bruker	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.64

Summary

Waters beats Bruker on 12 of the 17 factors compared between the two stocks.

How does Waters compare to Repligen?

Repligen (NASDAQ:RGEN) and Waters (NYSE:WAT) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability, media sentiment and analyst recommendations.

Repligen has a beta of 1.08, suggesting that its stock price is 8% more volatile than the broader market. Comparatively, Waters has a beta of 1.15, suggesting that its stock price is 15% more volatile than the broader market.

Waters has higher revenue and earnings than Repligen. Waters is trading at a lower price-to-earnings ratio than Repligen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Repligen	$738.26M	14.14	$48.89M	$0.73	253.43
Waters	$3.17B	13.24	$642.63M	$4.01	106.36

Repligen has a net margin of 5.29% compared to Waters' net margin of 3.58%. Waters' return on equity of 11.27% beat Repligen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Repligen	5.29%	5.30%	3.79%
Waters	3.58%	11.27%	6.73%

97.6% of Repligen shares are owned by institutional investors. Comparatively, 94.0% of Waters shares are owned by institutional investors. 0.6% of Repligen shares are owned by company insiders. Comparatively, 0.3% of Waters shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Repligen currently has a consensus target price of $168.57, suggesting a potential downside of 8.88%. Waters has a consensus target price of $437.10, suggesting a potential upside of 2.48%. Given Waters' higher probable upside, analysts clearly believe Waters is more favorable than Repligen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Repligen	0 Sell rating(s)	4 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.89
Waters	0 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	3 Strong Buy rating(s)	2.85

In the previous week, Waters had 2 more articles in the media than Repligen. MarketBeat recorded 13 mentions for Waters and 11 mentions for Repligen. Repligen's average media sentiment score of 0.23 beat Waters' score of 0.18 indicating that Repligen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Repligen	1 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Waters	3 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Waters beats Repligen on 9 of the 17 factors compared between the two stocks.

How does Waters compare to Bio-Techne?

Waters (NYSE:WAT) and Bio-Techne (NASDAQ:TECH) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

Bio-Techne has a net margin of 14.97% compared to Waters' net margin of 3.58%. Bio-Techne's return on equity of 13.23% beat Waters' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waters	3.58%	11.27%	6.73%
Bio-Techne	14.97%	13.23%	10.61%

Waters has higher revenue and earnings than Bio-Techne. Bio-Techne is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waters	$3.17B	13.24	$642.63M	$4.01	106.36
Bio-Techne	$1.22B	9.35	$181.86M	$1.15	62.96

94.0% of Waters shares are owned by institutional investors. Comparatively, 99.0% of Bio-Techne shares are owned by institutional investors. 0.3% of Waters shares are owned by company insiders. Comparatively, 1.3% of Bio-Techne shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Waters currently has a consensus price target of $437.10, suggesting a potential upside of 2.48%. Bio-Techne has a consensus price target of $68.92, suggesting a potential downside of 4.81%. Given Waters' stronger consensus rating and higher possible upside, research analysts plainly believe Waters is more favorable than Bio-Techne.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waters	0 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	3 Strong Buy rating(s)	2.85
Bio-Techne	0 Sell rating(s)	15 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.12

In the previous week, Waters had 9 more articles in the media than Bio-Techne. MarketBeat recorded 13 mentions for Waters and 4 mentions for Bio-Techne. Waters' average media sentiment score of 0.18 beat Bio-Techne's score of 0.07 indicating that Waters is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waters	3 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Bio-Techne	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Waters has a beta of 1.15, suggesting that its share price is 15% more volatile than the broader market. Comparatively, Bio-Techne has a beta of 1.3, suggesting that its share price is 30% more volatile than the broader market.

Summary

Waters beats Bio-Techne on 11 of the 17 factors compared between the two stocks.

How does Waters compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Waters (NYSE:WAT) are both large-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment.

In the previous week, Waters had 1 more articles in the media than Agilent Technologies. MarketBeat recorded 13 mentions for Waters and 12 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 0.29 beat Waters' score of 0.18 indicating that Agilent Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilent Technologies	2 Very Positive mention(s)	0 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Waters	3 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Agilent Technologies currently has a consensus price target of $170.33, indicating a potential upside of 1.26%. Waters has a consensus price target of $437.10, indicating a potential upside of 2.48%. Given Waters' stronger consensus rating and higher possible upside, analysts plainly believe Waters is more favorable than Agilent Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	0 Sell rating(s)	5 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.80
Waters	0 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	3 Strong Buy rating(s)	2.85

94.0% of Waters shares are owned by institutional investors. 0.3% of Waters shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Agilent Technologies has higher revenue and earnings than Waters. Agilent Technologies is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$6.95B	6.83	$1.30B	$5.08	33.11
Waters	$3.17B	13.24	$642.63M	$4.01	106.36

Agilent Technologies has a beta of 1.2, suggesting that its share price is 20% more volatile than the broader market. Comparatively, Waters has a beta of 1.15, suggesting that its share price is 15% more volatile than the broader market.

Agilent Technologies has a net margin of 19.53% compared to Waters' net margin of 3.58%. Agilent Technologies' return on equity of 24.45% beat Waters' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	19.53%	24.45%	13.09%
Waters	3.58%	11.27%	6.73%

Summary

Agilent Technologies beats Waters on 9 of the 17 factors compared between the two stocks.

How does Waters compare to Danaher?

Danaher (NYSE:DHR) and Waters (NYSE:WAT) are both large-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability.

Danaher has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market. Comparatively, Waters has a beta of 1.15, suggesting that its share price is 15% more volatile than the broader market.

79.1% of Danaher shares are held by institutional investors. Comparatively, 94.0% of Waters shares are held by institutional investors. 10.8% of Danaher shares are held by company insiders. Comparatively, 0.3% of Waters shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Danaher has a net margin of 15.95% compared to Waters' net margin of 3.58%. Waters' return on equity of 11.27% beat Danaher's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Danaher	15.95%	11.04%	6.81%
Waters	3.58%	11.27%	6.73%

Danaher has higher revenue and earnings than Waters. Danaher is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Danaher	$24.57B	6.15	$3.61B	$5.63	38.20
Waters	$3.17B	13.24	$642.63M	$4.01	106.36

Danaher currently has a consensus target price of $232.50, suggesting a potential upside of 8.11%. Waters has a consensus target price of $437.10, suggesting a potential upside of 2.48%. Given Danaher's stronger consensus rating and higher probable upside, equities analysts plainly believe Danaher is more favorable than Waters.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Danaher	0 Sell rating(s)	5 Hold rating(s)	17 Buy rating(s)	2 Strong Buy rating(s)	2.88
Waters	0 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	3 Strong Buy rating(s)	2.85

In the previous week, Danaher had 1 more articles in the media than Waters. MarketBeat recorded 14 mentions for Danaher and 13 mentions for Waters. Danaher's average media sentiment score of 0.96 beat Waters' score of 0.18 indicating that Danaher is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Danaher	7 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Waters	3 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Danaher beats Waters on 11 of the 17 factors compared between the two stocks.

Get Waters News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

WAT vs. The Competition

Export

Metric	Waters	Life Sciences Tools & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$41.81B	$10.67B	$7.11B	$22.72B
Dividend Yield	N/A	1.45%	2.53%	3.74%
P/E Ratio	106.13	75.03	274.42	27.75
Price / Sales	13.21	109.34	600.72	20.15
Price / Cash	26.42	27.76	77.38	39.56
Price / Book	9.90	6.85	10.92	4.64
Net Income	$642.63M	$57.48B	$3.50B	$1.08B
7 Day Performance	-1.93%	2.76%	-2.07%	-1.06%
1 Month Performance	3.26%	7.78%	-6.32%	-5.02%
1 Year Performance	32.34%	35.62%	8.92%	5.78%

Waters Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
WAT Waters	2.5037 of 5 stars	$425.59 +0.0%	$437.10 +2.7%	+33.0%	$41.81B	$3.17B	106.13	7,900	Analyst Forecast
BRKR Bruker	1.8974 of 5 stars	$63.28 -1.4%	$57.00 -9.9%	+78.4%	$9.78B	$3.44B	N/A	11,085	Analyst Forecast
RGEN Repligen	2.3763 of 5 stars	$194.09 +2.3%	$168.57 -13.1%	+21.5%	$10.70B	$738.26M	265.88	2,000	Analyst Forecast
TECH Bio-Techne	2.7442 of 5 stars	$72.51 -0.1%	$68.92 -4.9%	+20.8%	$11.39B	$1.22B	63.05	3,000
A Agilent Technologies	4.2403 of 5 stars	$175.42 +1.5%	$170.33 -2.9%	+19.9%	$48.71B	$6.95B	34.53	18,100

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:WAT) was last updated on 10/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Waters (WAT) Competitors